Latest Insider Transactions at Outset Medical, Inc. (OM)
This section provides a real-time view of insider transactions for Outset Medical, Inc. (OM). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Outset Medical, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Outset Medical, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 12
2024
|
Leslie Trigg Chair and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
457,438
+17.04%
|
-
|
|
Jan 12
2024
|
Nabeel Ahmed Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
241,904
+21.68%
|
-
|
|
Jan 08
2024
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
14,188
-3.52%
|
$70,940
$5.49 P/Share
|
|
Jan 08
2024
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
7,055
-6.24%
|
$35,275
$5.49 P/Share
|
|
Jan 08
2024
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
10,709
-12.23%
|
$53,545
$5.49 P/Share
|
|
Jan 08
2024
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
7,344
-13.08%
|
$36,720
$5.49 P/Share
|
|
Jan 08
2024
|
Stacey L. Porter Chief People Officer |
SELL
Open market or private sale
|
Direct |
4,766
-7.52%
|
$23,830
$5.49 P/Share
|
|
Jan 08
2024
|
Jean Olivier Racine Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
3,905
-5.03%
|
$19,525
$5.49 P/Share
|
|
Nov 16
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,175
-0.78%
|
$12,700
$4.76 P/Share
|
|
Nov 16
2023
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
3,584
-3.07%
|
$14,336
$4.76 P/Share
|
|
Nov 16
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,431
-2.49%
|
$5,724
$4.76 P/Share
|
|
Nov 16
2023
|
Marc Nash SVP Operations and R&D |
SELL
Open market or private sale
|
Direct |
562
-1.24%
|
$2,248
$4.76 P/Share
|
|
Nov 16
2023
|
Stacey L. Porter Chief People Officer |
SELL
Open market or private sale
|
Direct |
671
-1.05%
|
$2,684
$4.76 P/Share
|
|
Nov 16
2023
|
Jean Olivier Racine Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
790
-1.01%
|
$3,160
$4.76 P/Share
|
|
Nov 16
2023
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,643
-1.84%
|
$6,572
$4.76 P/Share
|
|
Sep 01
2023
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
545
-0.61%
|
$7,085
$13.61 P/Share
|
|
Aug 16
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
3,028
-0.74%
|
$45,420
$15.1 P/Share
|
|
Aug 16
2023
|
Steven S. Williamson Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
635
-0.54%
|
$9,525
$15.1 P/Share
|
|
Aug 16
2023
|
Stacey L. Porter Chief People Officer |
SELL
Open market or private sale
|
Direct |
638
-0.99%
|
$9,570
$15.1 P/Share
|
|
Aug 16
2023
|
Jean Olivier Racine Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
752
-0.95%
|
$11,280
$15.1 P/Share
|
|
Aug 16
2023
|
Marc Nash SVP Operations and R&D |
SELL
Open market or private sale
|
Direct |
535
-1.18%
|
$8,025
$15.1 P/Share
|
|
Aug 16
2023
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,565
-1.72%
|
$23,475
$15.1 P/Share
|
|
Aug 16
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,364
-2.31%
|
$20,460
$15.1 P/Share
|
|
Aug 01
2023
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
990
-1.08%
|
$19,800
$20.07 P/Share
|
|
Aug 01
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-4.66%
|
$400,000
$20.22 P/Share
|
|
Aug 01
2023
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+4.45%
|
$80,000
$4.11 P/Share
|
|
Jul 24
2023
|
Marc Nash SVP Operations and R&D |
BUY
Grant, award, or other acquisition
|
Direct |
6,338
+6.23%
|
-
|
|
Jul 19
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,415
-2.34%
|
$28,300
$20.0 P/Share
|
|
Jul 19
2023
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,415
+2.29%
|
$12,735
$9.48 P/Share
|
|
Jul 03
2023
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
990
-1.07%
|
$20,790
$21.7 P/Share
|
|
Jul 03
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-4.66%
|
$400,000
$20.9 P/Share
|
|
Jul 03
2023
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+4.45%
|
$80,000
$4.11 P/Share
|
|
Jun 20
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,414
-2.34%
|
$29,694
$21.97 P/Share
|
|
Jun 20
2023
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,414
+2.29%
|
$12,726
$9.48 P/Share
|
|
Jun 01
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
20,000
-4.66%
|
$420,000
$21.1 P/Share
|
|
Jun 01
2023
|
Leslie Trigg Chair and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
20,000
+4.45%
|
$80,000
$4.11 P/Share
|
|
Jun 01
2023
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
990
-1.06%
|
$19,800
$20.83 P/Share
|
|
May 31
2023
|
Catherine M. Szyman Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+23.8%
|
-
|
|
May 31
2023
|
James F. Hinrichs Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+12.19%
|
-
|
|
May 31
2023
|
Dale E Jones Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+26.86%
|
-
|
|
May 31
2023
|
Patrick T Hackett Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+30.09%
|
-
|
|
May 31
2023
|
Andrea Lynn Saia Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+25.12%
|
-
|
|
May 31
2023
|
D Keith Grossman Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+30.09%
|
-
|
|
May 31
2023
|
Karen Drexler Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,681
+24.85%
|
-
|
|
May 17
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
2,732
-2.24%
|
$54,640
$20.08 P/Share
|
|
May 17
2023
|
John L. Brottem General Counsel |
BUY
Exercise of conversion of derivative security
|
Direct |
1,415
+2.24%
|
$12,735
$9.48 P/Share
|
|
May 16
2023
|
John L. Brottem General Counsel |
SELL
Open market or private sale
|
Direct |
1,335
-2.17%
|
$25,365
$19.91 P/Share
|
|
May 16
2023
|
Jean Olivier Racine Chief Technology Officer |
SELL
Open market or private sale
|
Direct |
735
-0.92%
|
$13,965
$19.91 P/Share
|
|
May 16
2023
|
Leslie Trigg Chair and CEO |
SELL
Open market or private sale
|
Direct |
2,962
-0.72%
|
$56,278
$19.91 P/Share
|
|
May 16
2023
|
Nabeel Ahmed Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,532
-1.61%
|
$29,108
$19.91 P/Share
|